MR-guided radiation for hard-to-treat central lung tumors
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a specialized radiation therapy that uses daily MRI scans to precisely target lung tumors located near the windpipe or esophagus. It aims to improve treatment accuracy while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a lung tumor (either starting in the lung or spread from another cancer) that is located very close to the windpipe, major airways, or esophagus.
- Your tumor can be treated with a high-dose, precise type of radiation called SBRT, as recommended by your cancer team.
- You are 18 years or older.
- You do not have a pacemaker, metal implants, or other reasons that make MRI unsafe.
- You have not had radiation therapy to the exact same spot before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests an MRI-guided, highly targeted radiation treatment (SBRT) for tumors that have spread to the liver. It may help shrink 1–3 liver metastases while using imaging to better guide treatment.
This trial tests a precise type of radiation (stereotactic body radiotherapy) using a special MRI-guided machine for lung tumors that are very close to the main airways. It might help patients who cannot have surgery and whose tumor is in a hard-to-treat spot.
This trial tests a new way to deliver radiation to brain metastases from non-small cell lung cancer, using MRI scans to guide the treatment and reduce the area exposed. The goal is to see if this approach is safe and effective while possibly lowering side effects.
This trial studies a focused, high-dose radiation treatment called SBRT for lung tumors that are hard to operate on, including very central tumors near major airways or organs. It may help people control tumor growth while limiting radiation exposure to nearby critical structures.
This feasibility study tests whether MRI-guided, highly focused radiation can be safely delivered to tumors in the abdomen or central lung. It may help patients with a small number of metastases by aiming treatment more precisely and gathering detailed outcomes for future care.
This trial studies a precise, high-dose radiation technique (SBRT) to treat tumors in the lungs. It may help control cancer in people who either have early-stage lung cancer that is not fully operable or have limited lung metastases from other cancers.
Hear when a new Primary Lung Cancer or Secondary Lung Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.